Broadcom's guidance sent the stock tumbling this week. A buying opportunity has emerged

Broadcom reported Q2 revenue of $22.19 billion versus $22.13 billion consensus, but shares fell about 15% as Q3 AI chip revenue guidance of $16 billion missed the $17 billion whisper number. The article argues the selloff reflects short-term positioning and profit-taking rather than weak fundamentals, noting AVGO was trading around $405 with support near $400. An options trade was highlighted to define risk: sell the $400 7/17/2026 put for $22.75, buy the $370 put for $9.75, and buy the $430 call for $17.75, costing about $5 and offering upside above $435.

Analysis

The key market signal is not that AVGO’s fundamentals deteriorated; it is that the stock is being priced like a momentum AI proxy rather than a cash-generative infrastructure compounder. That mismatch creates a classic post-earnings dislocation: when guidance fails to clear an elevated whisper bar, systematic selling can push implied volatility and price far below where fundamental buyers normally step in. The result is a tactical opportunity, but only because the selloff is about positioning and expectations compression, not thesis breakage.

Second-order, the disappointment in Broadcom’s AI ramp is likely to hit adjacent high-beta semi names through sympathy de-risking, especially if funds are using AVGO as a liquid expression of the AI capex theme. That said, NVDA is less directly exposed here than the market reaction suggests; Broadcom’s miss is more about custom silicon and networking cadence than about the broader GPU demand curve. In other words, this is a rotation event within AI infrastructure, not necessarily a regime change for AI spend.

The best risk-reward is to express a rebound view with defined downside because the near-term path will remain flow-driven. If the stock can stabilize above the prior technical shelf, the unwind of short-term profit-taking could be fast over 2-6 weeks, but a failure to hold support would likely invite another leg down as analysts trim near-term estimates and momentum funds exit. The contrarian view is that the market may be correctly de-rating the multiple if investors can no longer assume every quarter will come with aggressive upside guide, so timing matters more than direction.

Key Decisions for Investors

• Buy AVGO on further weakness into the $390-$400 zone with a 2-6 week horizon; target a reflex move back toward the low-$430s if support holds, with a stop on a decisive break below the technical shelf.
• Use options to express upside convexity: long AVGO call spreads or risk-defined structures 1-3 months out, since the post-earnings vol reset improves entry and caps downside if the selloff extends.
• Pair trade: long AVGO / short a basket of high-beta AI infrastructure names that trade on similar sentiment but have less durable cash-flow support; this isolates the valuation re-rating risk from the broader AI theme.
• Avoid chasing NVDA weakness as a direct hedge against this event; if anything, use any sympathy dip in NVDA as a separate entry opportunity because the selloff is more about AVGO-specific guidance optics than end-demand deterioration.
• If AVGO cannot reclaim support within 1-2 weeks, reduce exposure rather than average down aggressively; the main tail risk is that systematic de-rating persists for several more earnings cycles if whisper expectations keep outrunning management guidance.